Compare PCRX & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | PRSU |
|---|---|---|
| Founded | 2006 | 1926 |
| Country | United States | United States |
| Employees | N/A | 2100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2010 | N/A |
| Metric | PCRX | PRSU |
|---|---|---|
| Price | $22.41 | $50.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $30.25 | ★ $31.67 |
| AVG Volume (30 Days) | ★ 359.7K | 199.1K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $6.78 | $4.85 |
| Revenue Next Year | $8.54 | $4.94 |
| P/E Ratio | $324.00 | ★ $3.45 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $26.99 |
| 52 Week High | $27.64 | $49.95 |
| Indicator | PCRX | PRSU |
|---|---|---|
| Relative Strength Index (RSI) | 41.76 | 78.56 |
| Support Level | $22.04 | $32.90 |
| Resistance Level | $23.97 | N/A |
| Average True Range (ATR) | 0.74 | 1.24 |
| MACD | -0.02 | 0.39 |
| Stochastic Oscillator | 21.43 | 82.68 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, Iceland and Costa Rica. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.